Literature DB >> 30919993

Evaluation of Ovarian Vascularity in Children by Using the "Superb Microvascular Imaging" Ultrasound Technique in Comparison With Conventional Doppler Ultrasound Techniques.

Ercan Ayaz1, Ahmet Aslan2, İbrahim İnan3, Ali Yıkılmaz2.   

Abstract

OBJECTIVES: The aim of this study was to assess the feasibility of the novel "superb microvascular imaging" (SMI) Doppler ultrasound technique to detect ovarian vascularity in healthy children and to compare it with the conventional Doppler ultrasound techniques.
METHODS: This prospective study included 140 girls, aged 3 to 18 years, for which an abdominal ultrasound study was requested in the pediatrics outpatient clinics for suspicion of nonovarian pathologies. Nineteen individuals were excluded from the study due to incomplete ultrasound scanning. For the remaining 121 cases, gray scale ultrasound evaluation was performed followed by color Doppler imaging, power Doppler imaging, advanced dynamic flow, color SMI, and monochrome SMI to detect the presence and degree of vascularity in the ovaries. Ultrasound scanning was performed for all participants by the same doctor by using curvilinear probe via the suprapubic approach, and the images were independently evaluated by 3 different observers. The images were assessed with regard to the degree of vascularity and the presence of artifacts.
RESULTS: A total of 146 ovaries (42 right, 54 left, and 25 bilateral) were examined by sonography. The mean interrater agreement regarding the detection of vascularity was moderate for the color Doppler imaging, power Doppler imaging, advanced dynamic flow, and monochrome SMI techniques (κ = 0.514-0.551) and substantial for the color SMI technique (κ = 0.636) (P < .001). The techniques were found to be statistically significant for detecting vascularity: monochrome SMI > color SMI > power Doppler imaging > color Doppler imaging > advanced dynamic flow (P < .001).
CONCLUSION: SMI is a promising tool that can detect ovarian vascularity more effectively than the conventional Doppler ultrasound techniques.
© 2019 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  Doppler sonography; ovarian torsion; ovarian vascularity; superb microvascular imaging, SMI

Mesh:

Year:  2019        PMID: 30919993     DOI: 10.1002/jum.14983

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  5 in total

1.  Comparison of superb microvascular imaging (SMI) quantified with ImageJ to quantified contrast-enhanced ultrasound (qCEUS) in liver metastases-a pilot study.

Authors:  Wolfgang Kratzer; Melanie Güthle; Felix Dobler; Thomas Seufferlein; Tilmann Graeter; Julian Schmidberger; Thomas Fe Barth; Jochen Klaus
Journal:  Quant Imaging Med Surg       Date:  2022-03

2.  Superb Microvascular Imaging (SMI) Compared with Color Doppler Ultrasound for the Assessment of Hepatic Artery in Pediatric Liver Transplants: A Feasibility Study.

Authors:  Elona Collaku; Roberto Simonini; Maurizio Balbi; Pietro Andrea Bonaffini; Clarissa Valle; Cesare Morzenti; Romina Fatima Faseli; Alberto Ferrari; Davide Ippolito; Paolo Marra; Tiziano Barbui; Sandro Sironi
Journal:  Diagnostics (Basel)       Date:  2022-06-16

Review 3.  Ultrasonographic Demonstration of the Tissue Microvasculature in Children: Microvascular Ultrasonography Versus Conventional Color Doppler Ultrasonography.

Authors:  Joonghyun Yoo; Bo Kyung Je; Ji Yung Choo
Journal:  Korean J Radiol       Date:  2020-02       Impact factor: 3.500

Review 4.  The Use of Transabdominal Ultrasound in Inflammatory Bowel Disease.

Authors:  Jiro Hata; Hiroshi Imamura
Journal:  Korean J Radiol       Date:  2022-03       Impact factor: 3.500

5.  Superb microvascular imaging technique in depicting vascularity in focal liver lesions: more hypervascular supply patterns were depicted in hepatocellular carcinoma.

Authors:  Fan Yang; Jing Zhao; Chunwei Liu; Yiran Mao; Jie Mu; Xi Wei; Jinyan Jia; Sheng Zhang; Xiaojie Xin; Jian Tan
Journal:  Cancer Imaging       Date:  2019-12-30       Impact factor: 3.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.